<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR3">
 <label>3.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Paavonen</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Jenkins</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Bosch</surname>
    <given-names>FX</given-names>
   </name>
   <name>
    <surname>Naud</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Salmer√≥n</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Wheeler</surname>
    <given-names>CM</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Efficacy of a prophylactic adjuvanted bivalent L1virus-like-particle vaccine against infection with human papillomavirus types16and18 in young women: an interim analysis of a phase III double-blind, randomized controlled trial</article-title>
  <source>Lancet</source>
  <year>2007</year>
  <volume>369</volume>
  <issue>9580</issue>
  <fpage>2161</fpage>
  <lpage>2170</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60946-5</pub-id>
  <?supplied-pmid 17602732?>
  <pub-id pub-id-type="pmid">17602732</pub-id>
 </element-citation>
</ref>
